The uptake of glutamine mediated by ASCT2, followed by its rapid efflux via LAT1 in exchange for EAAs such as leucine, is the rate-limiting step for mTOR signaling activation in tumor cells [59]. Here, SLC7A5 is linked to neoplasm.